CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Scientific Officer gave up 7,204 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,699 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 10,905 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,437 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,437 shares (to pay taxes)
- 4 Gift President & CEO gave 4,000 shares (gift)
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Shareholder vote results
- 8-K Event New debt or obligation
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 14 of 47 · 923 filings